1-9 of 9
Andreas Unterberg
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Effective Reprogramming of Patient-Derived M2-Polarized Glioblastoma-Associated Microglia/Macrophages by Treatment with GW2580

Valentina Fermi, Rolf Warta, Amélie Wöllner, Catharina Lotsch, Lena Jassowicz, Carmen Rapp, Maximilian Knoll, Gerhard Jungwirth, Christine Jungk, Philip Dao Trong, Andreas von Deimling, Amir Abdollahi, Andreas Unterberg, Christel Herold-Mende
Journal: Clinical Cancer Research
Clin Cancer Res (2023) 29 (22): 4685–4697.
https://doi.org/10.1158/1078-0432.CCR-23-0576
Published: 14 November 2023
View article titled, Effective Reprogramming of Patient-Derived M2-Polarized Glioblastoma-Associated Microglia/Macrophages by Treatment with GW2580
Open the PDF for Effective Reprogramming of Patient-Derived M2-Polarized Glioblastoma-Associated Microglia/Macrophages by Treatment with GW2580 in another window
Includes: Supplementary data
Journal Articles

Pharmacological Landscape of FDA-Approved Anticancer Drugs Reveals Sensitivities to Ixabepilone, Romidepsin, Omacetaxine, and Carfilzomib in Aggressive Meningiomas

Gerhard Jungwirth, Tao Yu, Fang Liu, Junguo Cao, Montadar Alaa Eddine, Mahmoud Moustafa, Amir Abdollahi, Rolf Warta, Andreas Unterberg, Christel Herold-Mende
Journal: Clinical Cancer Research
Clin Cancer Res (2023) 29 (1): 233–243.
https://doi.org/10.1158/1078-0432.CCR-22-2085
Published: 04 January 2023
View article titled, Pharmacological Landscape of FDA-Approved Anticancer Drugs Reveals Sensitivities to Ixabepilone, Romidepsin, Omacetaxine, and Carfilzomib in Aggressive Meningiomas
Open the PDF for Pharmacological Landscape of FDA-Approved Anticancer Drugs Reveals Sensitivities to Ixabepilone, Romidepsin, Omacetaxine, and Carfilzomib in Aggressive Meningiomas in another window
Includes: Supplementary data
Journal Articles

Surfactant Expression Defines an Inflamed Subtype of Lung Adenocarcinoma Brain Metastases that Correlates with Prolonged Survival

Kolja Pocha, Andreas Mock, Carmen Rapp, Steffen Dettling, Rolf Warta, Christoph Geisenberger, Christine Jungk, Leila R. Martins, Niels Grabe, David Reuss, Juergen Debus, Andreas von Deimling, Amir Abdollahi, Andreas Unterberg, Christel C. Herold-Mende
Journal: Clinical Cancer Research
Clin Cancer Res (2020) 26 (9): 2231–2243.
https://doi.org/10.1158/1078-0432.CCR-19-2184
Published: 01 May 2020
View article titled, Surfactant Expression Defines an Inflamed Subtype of Lung Adenocarcinoma Brain Metastases that Correlates with Prolonged Survival
Open the PDF for Surfactant Expression Defines an Inflamed Subtype of Lung Adenocarcinoma Brain Metastases that Correlates with Prolonged Survival in another window
Includes: Supplementary data
Journal Articles

Cytotoxic T Cells and their Activation Status are Independent Prognostic Markers in Meningiomas

Carmen Rapp, Steffen Dettling, Fang Liu, Anna Theresa Ull, Rolf Warta, Christine Jungk, Saskia Roesch, Andreas Mock, Felix Sahm, Melissa Schmidt, Gerhard Jungwirth, Klaus Zweckberger, Katrin Lamszus, Konstaninos Gousias, Almuth F. Kessler, Niels Grabe, Mario Loehr, Ralf Ketter, Steffi Urbschat, Christian Senft, Manfred Westphal, Amir Abdollahi, Juergen Debus, Andreas von Deimling, Andreas Unterberg, Matthias Simon, Christel C. Herold-Mende
Journal: Clinical Cancer Research
Clin Cancer Res (2019) 25 (17): 5260–5270.
https://doi.org/10.1158/1078-0432.CCR-19-0389
Published: 03 September 2019
View article titled, Cytotoxic T Cells and their Activation Status are Independent Prognostic Markers in Meningiomas
Open the PDF for Cytotoxic T Cells and their Activation Status are Independent Prognostic Markers in Meningiomas in another window
Includes: Supplementary data
Journal Articles

Identification of CRKII, CFL1, CNTN1, NME2, and TKT as Novel and Frequent T-Cell Targets in Human IDH-Mutant Glioma

Steffen Dettling, Slava Stamova, Rolf Warta, Martina Schnölzer, Carmen Rapp, Anchana Rathinasamy, David Reuss, Kolja Pocha, Saskia Roesch, Christine Jungk, Uwe Warnken, Volker Eckstein, Niels Grabe, Christoph Schramm, Markus A. Weigand, Andreas von Deimling, Andreas Unterberg, Philipp Beckhove, Christel Herold-Mende
Journal: Clinical Cancer Research
Clin Cancer Res (2018) 24 (12): 2951–2962.
https://doi.org/10.1158/1078-0432.CCR-17-1839
Published: 14 June 2018
View article titled, Identification of CRKII, CFL1, CNTN1, NME2, and TKT as Novel and Frequent T-Cell Targets in Human IDH-Mutant Glioma
Open the PDF for Identification of CRKII, CFL1, CNTN1, NME2, and TKT as Novel and Frequent T-Cell Targets in Human IDH-Mutant Glioma in another window
Includes: Supplementary data
Journal Articles

Effector T-Cell Infiltration Positively Impacts Survival of Glioblastoma Patients and Is Impaired by Tumor-Derived TGF-β

Jennifer Lohr, Thomas Ratliff, Andrea Huppertz, Yingzi Ge, Christine Dictus, Rezvan Ahmadi, Stefan Grau, Nobuyoshi Hiraoka, Volker Eckstein, Rupert C. Ecker, Thomas Korff, Andreas von Deimling, Andreas Unterberg, Philipp Beckhove, Christel Herold-Mende
Journal: Clinical Cancer Research
Clin Cancer Res (2011) 17 (13): 4296–4308.
https://doi.org/10.1158/1078-0432.CCR-10-2557
Published: 05 July 2011
View article titled, Effector T-Cell Infiltration Positively Impacts Survival of Glioblastoma Patients and Is Impaired by Tumor-Derived TGF-β
Open the PDF for Effector T-Cell Infiltration Positively Impacts Survival of Glioblastoma Patients and Is Impaired by Tumor-Derived TGF-β in another window
Includes: Supplementary data
Journal Articles

Differentiation Therapy Exerts Antitumor Effects on Stem-like Glioma Cells

Benito Campos, Feng Wan, Mohammad Farhadi, Aurélie Ernst, Felix Zeppernick, Katrin E. Tagscherer, Rezvan Ahmadi, Jennifer Lohr, Christine Dictus, Georg Gdynia, Stephanie E. Combs, Violaine Goidts, Burkhard M. Helmke, Volker Eckstein, Wilfried Roth, Philipp Beckhove, Peter Lichter, Andreas Unterberg, Bernhard Radlwimmer, Christel Herold-Mende
Journal: Clinical Cancer Research
Clin Cancer Res (2010) 16 (10): 2715–2728.
https://doi.org/10.1158/1078-0432.CCR-09-1800
Published: 13 May 2010
View article titled, Differentiation Therapy Exerts Antitumor Effects on Stem-like Glioma Cells
Open the PDF for Differentiation Therapy Exerts Antitumor Effects on Stem-like Glioma Cells in another window
Includes: Supplementary data
Journal Articles

Genomic and Expression Profiling of Glioblastoma Stem Cell–Like Spheroid Cultures Identifies Novel Tumor-Relevant Genes Associated with Survival

Aurélie Ernst, Stefanie Hofmann, Rezvan Ahmadi, Natalia Becker, Andrey Korshunov, Felix Engel, Christian Hartmann, Jörg Felsberg, Michael Sabel, Heike Peterziel, Moritz Durchdewald, Jochen Hess, Sebastian Barbus, Benito Campos, Anna Starzinski-Powitz, Andreas Unterberg, Guido Reifenberger, Peter Lichter, Christel Herold-Mende, Bernhard Radlwimmer
Journal: Clinical Cancer Research
Clin Cancer Res (2009) 15 (21): 6541–6550.
https://doi.org/10.1158/1078-0432.CCR-09-0695
Published: 02 November 2009
View article titled, Genomic and Expression Profiling of Glioblastoma Stem Cell–Like Spheroid Cultures Identifies Novel Tumor-Relevant Genes Associated with Survival
Open the PDF for Genomic and Expression Profiling of Glioblastoma Stem Cell–Like Spheroid Cultures Identifies Novel Tumor-Relevant Genes Associated with Survival in another window
Includes: Supplementary data
Journal Articles

Stem Cell Marker CD133 Affects Clinical Outcome in Glioma Patients

Felix Zeppernick, Rezvan Ahmadi, Benito Campos, Christine Dictus, Burkhard M. Helmke, Natalia Becker, Peter Lichter, Andreas Unterberg, Bernhard Radlwimmer, Christel C. Herold-Mende
Journal: Clinical Cancer Research
Clin Cancer Res (2008) 14 (1): 123–129.
https://doi.org/10.1158/1078-0432.CCR-07-0932
Published: 02 January 2008
View article titled, Stem Cell Marker CD133 Affects Clinical Outcome in Glioma Patients
Open the PDF for Stem Cell Marker CD133 Affects Clinical Outcome in Glioma Patients in another window